Sigachi Industries Limited
Sigachi Industries Limited (SIGACHI): company summary
The company's business has deteriorated, with annual net profit swinging from a profit of ₹70 crore to a loss of ₹83 crore.
Sigachi Industries Limited (SIGACHI) is a micro-cap Healthcare company valued at ₹1,052 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Sigachi Industries Limited last traded at ₹27.43, modestly down 0.94% on the day.
- Recent developments
- On 2026-08-07, the company informed the Exchange about a Board Meeting scheduled for 13-Aug-2026 to consider and approve the unaudited financial results for the quarter ending 2026-06-30.
- Financial performance
- The company's business has deteriorated, with annual net profit swinging from a profit of ₹70 crore to a loss of ₹83 crore. The latest quarter showed a turnaround, with net profit turning from a loss of ₹101 crore to a profit of ₹8 crore, but revenue fell 5.4% year-on-year to ₹121 crore.
- Valuation multiples
- The stock trades at 54.5 times earnings, a premium to the Healthcare median of 32.0, 2.76 times book value. It yields 0.3%.
- Things to watch
- The company reported a net loss of ₹83 crore in its latest financial year, with net profit margin falling to -17.3% from 14.3% the prior year. The latest quarter net profit swung from a loss to a profit, but revenue declined year-on-year, and the stock is 30.6% below its 52-week high.
- Where it stands
- Sigachi Industries Ltd ended the latest quarter with a net profit of ₹8 crore, but the company reported a net loss of ₹83 crore for the latest financial year. The stock is 30.6% below its 52-week high, and the net profit margin has dropped significantly to -17.3%.
Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (7.5), but held back by quality (2.0). Growth looks strong at 7.5, but that is offset by quality at 2.0 and valuation at 2.7. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Revenue compounding 20% a year
- Quality is weak (2.0/10)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Sigachi Industries Limited’s valuation
Free deep-dive tools · no sign-up
Sigachi Industries Limited peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare Sigachi Industries Limited with peers
Related tools & concepts
Value Sigachi Industries Limited with the ratios and calculators DocStoX uses in its analysis.

